Validate Your 2nd Culture Media Supplier and Eliminate Single-Source Risk

Webinar - 11 December, 2025 | 2 PM GMT | 9 AM ET | 6 AM PT | 3 PM CET

pmm_logo
GDM logo
NPC

In this webinar, hosted by rapidmicrobiology you will learn from culture media experts as they share practical insights on why and how to validate a secondary culture media supplier.

In pharmaceutical microbiology, environmental monitoring (EM) is a cornerstone of contamination control and quality assurance. Culture media, used to recover and enumerate viable microorganisms from controlled environments, plays a critical role in the reliability of EM results. Given its impact on product safety and regulatory compliance, sourcing culture media from a reliable and validated supplier is essential. Equally important, however, is the validation of a second supplier. This step, often overlooked or delayed, is vital for ensuring production continuity and mitigating supply chain risks.

This webinar offers an in-depth look at:

  • Why relying on a single supplier for culture media is a high-risk strategy.
  • How global regulatory bodies, including the FDA, EMA, and PIC/S, expect pharmaceutical companies to manage supplier risks proactively.
  • How, by qualifying a second supplier, pharmaceutical companies can build resilience into their supply chain.
  • Why validating a second supplier of culture media for environmental monitoring is not a procurement strategy but a quality imperative.

Can’t make it? Register anyway and we’ll send you the recording.

About the Speakers

Ulrich

Ulrich Eikmanns, PharmaMedia Dr. Müller GmbH

Ulrich is a Biologist who has specialized in Microbiology. He started his career in a diagnostic company which provided solutions for the quality control of proteins. Following on from this, Ulrich was employed at an API manufacturer. In 2001, Ulrich joined a leading media manufacturer of environmental monitoring media as head of the Product Management Department. Since 2013 he has been Managing Director of PharmaMedia Dr. Müller GmbH, a company which specialized in the production of high-quality culture media, as well as a state-of-the art service to customers of the pharmaceutical industry worldwide. Thanks to his many years of experience in Microbiology and ready-to-use culture media applications, for 25 years Ulrich has contributed to innovations and developments in the field of environmental monitoring. In the past, he participated in the development of pioneering approaches for the usage of plated media in environmental monitoring which are now considered as standard.
Peter-1

Peter Penn, NPC Ltd

Peter began his career as a Biomedical Scientist specialising in Microbiology and subsequently gained Senior Status in the UK Healthcare System.  His commercial career involved extensive worldwide travel managing many areas of microbiology, training sales teams, attending major international shows and helping companies not only meet but exceed ambitious sales targets.  Having presented in many international scientific meetings Peter has considerable experience in delivering presentations and holding workshops for both Pharmaceutical and Food Microbiology users, particularly with reference to phenotypic identification, growth promotion testing and environmental monitoring.
Gilberto-1

Gilberto Dalmaso, GDM

Gilberto Dalmaso is a globally recognized expert in pharmaceutical quality microbiology, with over 35 years of experience in the pharmaceutical industry. He has successfully operated in culturally diverse and cross-functional environments, specializing in Pharma Process Understanding, Quality by Design, and Quality Systems design and review.
Gilberto is a certified auditor for pharmaceuticals and medical devices, with deep knowledge of cGMP, GDP, ICH, and aseptic process regulations. He has managed over 40 regulatory inspections, including those by the US FDA, and possesses hands-on expertise in Lean Manufacturing and Six Sigma methodologies.
Gilberto is fluent in both Italian and English and is well-versed in Japanese quality requirements. His key knowledge areas include Quality Management Systems, GMP regulations, Risk Management, and Process Analytical Technologies, making him a highly versatile and effective leader in the pharmaceutical quality sector.